Projects and Grants per year
Personal profile
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
2021
Residency, University Of Missouri- Kansas City
2018
Doctor of Medicine, Hashemite University
2012
-
24-LEUK-27-DS(AC220-168): Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed F
Qasrawi, A. (PI)
4/22/25 → 4/22/27
Project: Research project
-
Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor
Piranavan, P. (PI), Ahmed, S. (CoI), Alkilany, R. (CoI) & Qasrawi, A. (CoI)
11/8/24 → 12/21/30
Project: Research project
-
24-LEUK-26-OV (OV-AML-1231): A Multicenter, Open-label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy
Qasrawi, A. (PI)
9/4/24 → 9/4/26
Project: Research project
-
24-LEUK-25-KO-PMC (KO-MEN-007): Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination with Ziftomenib (KO-539) or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib for the Treatment of Patients wit
Qasrawi, A. (PI)
8/14/24 → 8/14/26
Project: Research project
-
23-HEM-20-SA (EFC17757): A Randomized, Double-blind, Multicenter,Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age W
Qasrawi, A. (PI) & Ramlal, R. (Former PI)
4/1/24 → 4/1/26
Project: Research project